These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 18069515)
1. [Mechanisms of neuronal death in Huntington's disease. First part: general considerations and histopathological features]. Bantubungi K; Blum D Rev Med Brux; 2007; 28(5):413-21. PubMed ID: 18069515 [TBL] [Abstract][Full Text] [Related]
2. [Mechanisms of neuronal death in Huntington's disease. Second part: therapeutic challenges]. Bantubungi K; Blum D Rev Med Brux; 2007; 28(6):487-94. PubMed ID: 18265808 [TBL] [Abstract][Full Text] [Related]
9. Animal models of Huntington's disease: implications in uncovering pathogenic mechanisms and developing therapies. Wang LH; Qin ZH Acta Pharmacol Sin; 2006 Oct; 27(10):1287-302. PubMed ID: 17007735 [TBL] [Abstract][Full Text] [Related]
10. Aging and neurodegeneration. Molecular mechanisms of neuronal loss in Huntington's disease. Lee ST; Kim M Mech Ageing Dev; 2006 May; 127(5):432-5. PubMed ID: 16527334 [TBL] [Abstract][Full Text] [Related]
12. Gene Therapy-Based Modeling of Neurodegenerative Disorders: Huntington's Disease. Young D Methods Mol Biol; 2016; 1382():383-95. PubMed ID: 26611601 [TBL] [Abstract][Full Text] [Related]
13. Huntington's disease: how does huntingtin, an anti-apoptotic protein, become toxic? Rangone H; Humbert S; Saudou F Pathol Biol (Paris); 2004 Jul; 52(6):338-42. PubMed ID: 15261377 [TBL] [Abstract][Full Text] [Related]
14. The clinical and genetic features of Huntington disease. Sturrock A; Leavitt BR J Geriatr Psychiatry Neurol; 2010 Dec; 23(4):243-59. PubMed ID: 20923757 [TBL] [Abstract][Full Text] [Related]
15. Unraveling a role for dopamine in Huntington's disease: the dual role of reactive oxygen species and D2 receptor stimulation. Charvin D; Vanhoutte P; Pagès C; Borrelli E; Caboche J Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12218-23. PubMed ID: 16103364 [TBL] [Abstract][Full Text] [Related]
16. Differential distribution of the normal and mutated forms of huntingtin in the human brain. Gourfinkel-An I; Cancel G; Trottier Y; Devys D; Tora L; Lutz Y; Imbert G; Saudou F; Stevanin G; Agid Y; Brice A; Mandel JL; Hirsch EC Ann Neurol; 1997 Nov; 42(5):712-9. PubMed ID: 9392570 [TBL] [Abstract][Full Text] [Related]
17. Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length. Becher MW; Kotzuk JA; Sharp AH; Davies SW; Bates GP; Price DL; Ross CA Neurobiol Dis; 1998 Apr; 4(6):387-97. PubMed ID: 9666478 [TBL] [Abstract][Full Text] [Related]
18. Loss of normal huntingtin function: new developments in Huntington's disease research. Cattaneo E; Rigamonti D; Goffredo D; Zuccato C; Squitieri F; Sipione S Trends Neurosci; 2001 Mar; 24(3):182-8. PubMed ID: 11182459 [TBL] [Abstract][Full Text] [Related]